Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More - Xconomy

Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More  Xconomy

Xconomy National —. The growing epidemic of the fatty liver disease known as NASH, which has no FDA-approved treatment, has led to a frenzied race among ...